Skip to main content

Table 2 Comparison of HDL components in non-diabetic subjects and T2DM patients

From: Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients

Characteristics

All

Female

Male

Non-diabetic

T2DM

Non-diabetic

T2DM

Non-diabetic

T2DM

N in category

298

300

149

150

149

150

Cholesterol (mg/dL)

53.8 (13.3)

46.8 (12.3)§

54.6 (12.8)

49.8 (9.7)Ç‚

52.9 (13.88)

43.8 (13.9)§

ApoA-I (μg/mL)

7.8 (2.2)

6.8 (2.6)§

7.5 (2.0)

6.9 (2.6)Å‚

8.0 (2.4)

6.9 (2.6)Ç‚

Serum amyloid A (μg/L)

811.9 (286.8)

928.5 (326.8)§

924.8 (265.3)

1021.9 (335.2)*

691.6 (244.4)

836.0 (291.0)§

Phospholipid (pg/mL)

963.8 (438.4)

1080.5 (391.1)Ç‚

992.4 (413.8)

1045.9 (349.6)

933.6 (462.3)

1115.1 (427.0)Ç‚

sphingosine-1-phosphate (nmol/L)

1549.7 (473.3)

1464.3 (699.9)

1465.0 (450.5)

1429.4 (769.2)

1629.3 (480.2)

1499.3 (623.6)*

Triglycerides (log, mg/dl)

13.6 (10.8–16.4)

13.0 (10.6–17.6)

12.3 (9.7–16.0)

15.0 (11.4–19.4)ǂ

14.0 (11.7–16.8)

11.8 (9.4–15.0)

  1. § p < 0.0001;ǂ p < 0.001; ł p < 0.01; * p < 0.05 when compared with non-diabetic controls